Palemo Holdings
2778
Spancrete
5277
Renascience
4889
Oncolys BioPharma
4588
Kitagawa Seiki
6327
(Q2)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash, cash equivalents and federal funds sold | -6.96%891.2B | -18.99%903.48B | -18.99%903.48B | -3.04%977.14B | -2.08%957.91B | -11.20%1.05T | -7.60%1.12T | -7.60%1.12T | -14.27%1.01T | -10.28%978.24B |
-Cash and cash equivalents | -7.07%883.87B | -19.16%896.18B | -19.16%896.18B | -3.06%970.3B | -2.09%951.08B | -11.27%1.04T | -7.64%1.11T | -7.64%1.11T | -14.35%1T | -10.37%971.41B |
-Including:Cash and bank accounts receivable | -7.07%883.87B | -19.16%896.18B | -19.16%896.18B | -3.06%970.3B | -2.09%951.08B | -11.27%1.04T | -7.64%1.11T | -7.64%1.11T | -14.35%1T | -10.37%971.41B |
-Restricted cash and investment | 7.44%7.34B | 7.32%7.3B | 7.32%7.3B | 0.04%6.84B | 0.00%6.83B | 0.00%6.82B | 0.00%6.8B | 0.00%6.8B | 0.04%6.84B | 4.63%6.83B |
Financial asset investment | 44.62%958.04B | 44.43%824.47B | 44.43%824.47B | 9.06%734.41B | -6.50%662.48B | -9.26%652.99B | -23.76%570.85B | -23.76%570.85B | -13.29%673.39B | 0.16%708.56B |
-Trading securities | ---- | --0 | --0 | --0 | -16.02%304M | -14.47%325M | -7.27%370M | -7.27%370M | -14.15%358M | -21.30%362M |
-Available-for-sale securities | 44.68%958.04B | 44.52%824.47B | 44.52%824.47B | 9.12%734.41B | -6.50%662.17B | -9.26%652.66B | -23.76%570.48B | -23.76%570.48B | -13.29%673.03B | 0.18%708.19B |
Net loan | 2.55%2.35T | 5.72%2.32T | 5.72%2.32T | 5.54%2.31T | 6.73%2.29T | 4.61%2.24T | 3.65%2.2T | 3.65%2.2T | 2.88%2.19T | 20.13%2.15T |
-Other loan assets | 2.50%2.37T | 5.68%2.34T | 5.68%2.34T | 5.56%2.33T | 6.72%2.31T | 4.60%2.26T | 3.57%2.21T | 3.57%2.21T | 2.78%2.21T | 20.15%2.17T |
-Allowance for loan and lease losses | -3.79%18.23B | 1.07%18.61B | 1.07%18.61B | 7.58%18.97B | 5.96%18.95B | 3.79%18.56B | -5.04%18.42B | -5.04%18.42B | -8.20%17.63B | 22.76%17.88B |
Net PPE | -1.42%30.66B | 0.01%31.17B | 0.01%31.17B | -0.79%31.02B | -0.38%31.1B | -0.63%30.96B | -0.94%31.17B | -0.94%31.17B | -3.51%31.27B | 5.25%31.22B |
-Gross PP&E | ---- | 0.00%31.17B | 0.00%31.17B | ---- | ---- | ---- | -0.93%31.17B | -0.93%31.17B | ---- | ---- |
Goodwill and other intangible assets | -8.65%1.07B | -1.08%1.19B | -1.08%1.19B | 8.92%1.18B | 0.26%1.17B | 1.41%1.22B | -1.88%1.2B | -1.88%1.2B | -12.20%1.09B | 230.03%1.17B |
-Other intangible assets | ---- | -1.08%1.19B | -1.08%1.19B | ---- | ---- | ---- | -1.88%1.2B | -1.88%1.2B | ---- | ---- |
Total tax assets | -51.80%3.07B | -67.88%2.04B | -67.88%2.04B | -49.54%3.6B | 3.42%6.36B | -23.64%3.59B | 332.33%6.34B | 332.33%6.34B | 643.59%7.13B | 543.20%6.15B |
-Deferred tax assets | -51.80%3.07B | -67.88%2.04B | -67.88%2.04B | -49.54%3.6B | 3.42%6.36B | -23.64%3.59B | 332.33%6.34B | 332.33%6.34B | 643.59%7.13B | 543.20%6.15B |
Other assets | 3.69%83.75B | -0.58%80.33B | -0.58%80.33B | -0.20%85.37B | -2.06%80.77B | 1.35%82.95B | -2.37%80.8B | -2.37%80.8B | 10.95%85.54B | 25.02%82.48B |
Total assets | 7.10%4.32T | 4.06%4.16T | 4.06%4.16T | 3.70%4.14T | 1.93%4.03T | -2.41%4.06T | -4.52%4T | -4.52%4T | -4.69%4T | 7.41%3.96T |
Liabilities | ||||||||||
Total deposits | -0.75%3.39T | 1.22%3.41T | 1.22%3.41T | 0.53%3.41T | 1.94%3.41T | 1.96%3.42T | 1.52%3.37T | 1.52%3.37T | 1.97%3.39T | 17.49%3.35T |
Trading and financial liabilities | 26.59%574.37B | 27.79%572.89B | 27.79%572.89B | 27.70%558.5B | 8.49%453.73B | -26.15%448.72B | -30.80%448.32B | -30.80%448.32B | -29.62%437.36B | -27.52%418.22B |
-Total debt | 26.59%574.37B | 27.79%572.89B | 27.79%572.89B | 27.70%558.5B | 8.49%453.73B | -26.15%448.72B | -30.80%448.32B | -30.80%448.32B | -29.62%437.36B | -27.52%418.22B |
Total provisions | -1.52%517M | -13.90%514M | -13.90%514M | 7.87%507M | -0.57%525M | -3.01%547M | 17.75%597M | 17.75%597M | -13.28%470M | -27.37%528M |
Total pension and other postretirement benefit plans | -5.36%6.14B | -4.52%6.25B | -4.52%6.25B | -0.99%6.23B | -0.81%6.49B | -1.73%6.25B | -3.65%6.55B | -3.65%6.55B | -0.90%6.29B | 13.56%6.54B |
Deferred income tax liabilities | -3.58%2.4B | -5.66%2.38B | -5.66%2.38B | 7.20%2.56B | 3.50%2.48B | 9.67%2.63B | 4.90%2.53B | 4.90%2.53B | -68.58%2.39B | -63.52%2.4B |
Other liabilities | 635.83%205.63B | -34.26%29.59B | -34.26%29.59B | -2.96%32.79B | -45.87%27.95B | -19.06%41.09B | -38.70%45.01B | -38.70%45.01B | -58.00%33.79B | -51.11%51.63B |
Total liability | 6.98%4.17T | 3.87%4.02T | 3.87%4.02T | 3.57%4.01T | 2.01%3.9T | -2.55%3.92T | -4.39%3.87T | -4.39%3.87T | -4.23%3.87T | 7.95%3.83T |
Shareholders'equity | ||||||||||
Share capital | 0.00%17.97B | 0.00%17.97B | 0.00%17.97B | 0.00%17.97B | 0.00%17.97B | 0.00%17.97B | 0.00%17.97B | 0.00%17.97B | 0.00%17.97B | 0.00%17.97B |
-common stock | 0.00%17.97B | 0.00%17.97B | 0.00%17.97B | 0.00%17.97B | 0.00%17.97B | 0.00%17.97B | 0.00%17.97B | 0.00%17.97B | 0.00%17.97B | 0.00%17.97B |
Additional paid-in capital | -0.03%6.3B | -0.02%6.3B | -0.02%6.3B | 0.78%6.3B | 0.80%6.3B | 5.48%6.3B | 5.48%6.3B | 5.48%6.3B | 4.64%6.25B | 4.64%6.25B |
Retained earnings | 6.57%100.42B | 2.74%95.6B | 2.74%95.6B | 1.58%94.73B | 0.48%94.23B | 0.41%93.32B | 0.72%93.05B | 0.72%93.05B | -0.50%93.26B | 5.13%93.78B |
Less: Treasury stock | 63.37%2.73B | -11.82%1.58B | -11.82%1.58B | 42.78%1.6B | 48.66%1.67B | 51.56%1.75B | 55.10%1.79B | 55.10%1.79B | -2.94%1.12B | -2.86%1.12B |
Fixed asset revaluation reserve | -0.09%5.41B | -0.28%5.41B | -0.28%5.41B | -0.37%5.41B | -0.70%5.41B | -0.70%5.41B | -0.77%5.42B | -0.77%5.42B | -0.53%5.43B | -0.13%5.45B |
Other reserves | 517.12%10.63B | 453.91%12.04B | 453.91%12.04B | 603.04%7.45B | 37.40%1.72B | 94.70%8.31B | -82.42%2.17B | -82.42%2.17B | -106.77%-1.48B | -94.15%1.25B |
Total stockholders'equity | 11.32%138B | 10.25%135.74B | 10.25%135.74B | 8.27%130.25B | 0.31%123.97B | 3.28%129.55B | -7.43%123.12B | -7.43%123.12B | -16.38%120.3B | -11.01%123.58B |
Noncontrolling interests | -0.11%5.71B | 3.22%5.77B | 3.22%5.77B | -5.74%5.8B | -10.25%5.71B | -20.43%5.75B | -26.66%5.59B | -26.66%5.59B | -25.44%6.15B | --6.36B |
Total equity | 10.82%143.71B | 9.94%141.51B | 9.94%141.51B | 7.59%136.05B | -0.20%129.68B | 1.99%135.3B | -8.47%128.71B | -8.47%128.71B | -16.87%126.45B | -6.42%129.94B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |